Cassava Sciences has announced plans to extend trials for its Alzheimer’s treatment drug. This news isn't helping SAVA stock. More
Articles
SOUN Stock Alert: SoundHound Expands AI Rollout with Stellantis
SoundHound AI stock is up on Tuesday as SOUN investors react well to the company's voice assistant coming to Stellantis vehicles. More
7 Small-Cap Stocks to Buy for Large-Scale Gains
Although small-cap stocks are incredibly risky, their underappreciated nature potentially gives them a high performance ceiling. More
Why Is CNS Pharmaceuticals (CNSP) Stock Down 69% Today?
CNS Pharmaceuticals stock is falling hard on Tuesday as CNSP investors aren't happy about its latest license expansion. More
The Top 3 Manufacturing Stocks to Buy Now: Summer 2024
If money continues to rotate away from the tech sector there may be some strong gains in these manufacturing stocks. More
Marjorie Taylor Greene Doubles Down on AI Boom With New Buys
Rep. Marjorie Taylor Greene has just disclosed several new trades. These include AI beneficiaries AMAT, DELL, GLW and DUK. More
Tesla Resistance Levels: Bulls Must Clear Post-Earnings Hurdles!
Watch closely for hard-to-break Tesla resistance levels, as an earnings disaster means Tesla stock has a lot of catching up to do. More